Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAIMA A ZAFAR

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1437131273
CMS profile
200405
Location
KAUFMAN, TX

General Payments · PY2018–2024

$3,019.75

  • Reported across 62 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$417.66

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $417.66 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
CVRx Inc. $223.93 3
Novo Nordisk AS $66.68 3
NOVARTIS PHARMACEUTICALS CORPORATION $32.96 2
Edwards Lifesciences Corporation $25.81 1
Merck Sharp & Dohme Corporation $20.44 1
Amgen Inc. $18.65 1
PFIZER INC. $15.23 1
Acerta Pharma LLC $13.96 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $168.11 12
PY2019 $201.64 12
PY2020 $133.06 2
PY2022 $12.17 1
PY2023 $2,087.11 22
PY2024 $417.66 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $18.65 04/10/2024 Food and Beverage Undisputed 01/23/2026 1116221290 CMS
AstraZeneca Pharmaceuticals LP $13.96 05/08/2024 Food and Beverage Undisputed 01/23/2026 1104660743 CMS
CVRx, Inc. $34.92 05/14/2024 Food and Beverage Undisputed 01/23/2026 1140963522 CMS
CVRx, Inc. $14.41 05/14/2024 Food and Beverage Undisputed 01/23/2026 1140963524 CMS
CVRx, Inc. $174.60 05/14/2024 Food and Beverage Undisputed 01/23/2026 1140963526 CMS
Edwards Lifesciences Corporation $25.81 08/20/2024 Food and Beverage Undisputed 01/23/2026 1138845635 CMS
Merck Sharp & Dohme LLC $20.44 08/06/2024 Food and Beverage Undisputed 01/23/2026 1141677691 CMS
Novartis Pharmaceuticals Corporation $19.12 03/27/2024 Food and Beverage Undisputed 01/23/2026 1087388664 CMS
Novartis Pharmaceuticals Corporation $13.84 10/30/2024 Food and Beverage Undisputed 01/23/2026 1087388674 CMS
Novo Nordisk Inc $21.05 03/20/2024 Food and Beverage Undisputed 01/23/2026 1097689534 CMS
Novo Nordisk Inc $22.11 07/17/2024 Food and Beverage Undisputed 01/23/2026 1096898147 CMS
Novo Nordisk Inc $23.52 10/29/2024 Food and Beverage Undisputed 01/23/2026 1096951193 CMS
PFIZER INC. $15.23 03/28/2024 Food and Beverage Undisputed 01/23/2026 1131357462 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.